IP Library Granted Patent US 11,299,774
Granted Patent B2
US 11,299,774 · App. 17/479,718 · Granted Apr 12, 2022

Spatially distinguished, multiplex nucleic acid analysis of biological specimens

Inventors: Jonas Frisen (Stockholm, SE); Patrik Stahl (Stockholm, SE); Joakim Lundeberg (Lidingö, SE); Gordon M. Cann (San Diego, CA); Leila Bazargan (San Diego, CA); Alex Aravanis (San Diego, CA)
Assignees: Spatial Transcriptomics AB; Illumina Inc
C12Q1/6834C12N15/1065C12Q1/6841C12Q1/6874C12Q1/6876
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,299,774
App. No.
17/479,718
Granted
Apr 12, 2022
Kind
B2
Abstract

A method for spatially tagging nucleic acids of a biological specimen, including steps of (a) providing a solid support comprising different nucleic acid probes that are randomly located on the solid support, wherein the different nucleic acid probes each includes a barcode sequence that differs from the barcode sequence of other randomly located probes on the solid support; (b) performing a nucleic acid detection reaction on the solid support to locate the barcode sequences on the solid support; (c) contacting a biological specimen with the solid support that has the randomly located probes; (d) hybridizing the randomly located probes to target nucleic acids from portions of the biological specimen; and (e) modifying the randomly located probes that are hybridized to the target nucleic acids, thereby producing modified probes that include the barcode sequences and a target specific modification, thereby spatially tagging the nucleic acids of the biological specimen.

Claims (37)

1. A method for determining the spatial location of target nucleic acids in a biological specimen, comprising:

(a) providing a solid support comprising a population of nucleic acids randomly located across a population of features of said solid support, wherein the nucleic acids comprise a spatial tag sequence and a primer binding sequence, and wherein the spatial tag sequence differs from spatial tag sequences of other nucleic acids in the population;

(b) performing a sequencing reaction to determine the spatial tag sequences, or complements thereof, of the nucleic acids located across the population of features on the solid support, thereby determining the positions of the spatial tag sequences on the solid support;

(c) contacting a biological specimen with the solid support;

(d) hybridizing the target nucleic acids from the biological specimen to capture sequences on the randomly located nucleic acids that are proximal to the target nucleic acids;

(e) extending the capture sequences, wherein the extended capture sequences comprise a complement of the target nucleic acid or a portion thereof,

(f) amplifying the extended capture sequences, the spatial tag sequence or a complement thereof and the primer binding site with a primer complementary to the primer binding site, thereby generating amplification products comprising the target nucleic acid or a complement thereof or a portion of the target nucleic acid or a complement thereof, and the spatial tag or a complement thereof, and

(g) performing a nucleic acid detection reaction on the amplification products to determine all or a portion of the target nucleic acid sequences or complements thereof, and the spatial tag sequences or complements thereof, thereby determining the spatial location of target nucleic acids in the biological specimen.

2. The method of claim 1 , wherein the sequencing reaction comprises sequencing-by-synthesis, sequencing-by-hybridization, or sequencing-by-ligation.

3. The method of claim 1 , wherein the primer binding sequence is the same on the population of nucleic acids.

4. The method of claim 1 , wherein the capture sequences on the randomly located nucleic acids comprise different target capture sequences that hybridize to different target nucleic acids from the biological specimen.

5. The method of claim 1 , wherein the capture sequences on the randomly located nucleic acids comprise a common target capture sequence, and the common target capture sequence comprises a polyT or polyA sequence.

6. The method of claim 1 , wherein the solid support comprises a gel coating.

7. The method of claim 1 , wherein the population of features is selected from the group consisting of pits, wells, channels, ridges, raised regions, pegs, posts and beads.

8. The method of claim 7 , wherein the population of features on the solid support have an average pitch of less than 10 μm.

9. The method of claim 7 , wherein the population of features on the solid support have an average pitch of less than 5 μm.

10. The method of claim 7 , wherein the population of features on the solid support have an average pitch of less than 1 μm.

11. The method of claim 1 , wherein the solid support includes fiducial markers.

12. The method of claim 1 , wherein the method further comprises a step of acquiring an image of the biological specimen in contact with the solid support, and a step of correlating the determined spatial tag sequences, or complements thereof, with locations in the image of the biological specimen.

13. The method of claim 1 , wherein the nucleic acid detection reaction in step (g) comprises sequencing.

14. The method of claim 13 , wherein sequencing comprises sequencing-by-synthesis, sequencing-by-hybridization, or sequencing-by-ligation.

15. The method of claim 1 , wherein the method further comprises, between steps (f) and (g), a step of removing the amplification products from the solid support.

16. The method of claim 15 , wherein the method further comprises pooling the amplification products to form a mixture of amplification products that have been removed from the solid support.

17. The method of claim 16 , wherein the method further comprises providing the mixture of amplification products that have been removed from the solid support to a second solid support.

18. The method of claim 17 , wherein the method further comprises determining the sequences of the mixture of amplification products on the second solid support.

19. The method of claim 1 , wherein the solid support is located in or on a flow cell.

20. The method of claim 1 , wherein the biological specimen is a mixture of cells and step (c) further comprises contacting the cells to the solid support and/or lysing the cells to release the target nucleic acids from the cells.

21. The method of claim 1 , wherein the biological specimen is a tissue and step (c) further comprises permeabilizing the tissue to release the target nucleic acids from the tissue.

22. The method of claim 1 , wherein the target nucleic acids are RNA.

23. The method of claim 22 , wherein the RNA is mRNA.

24. The method of claim 1 , wherein the target nucleic acids are DNA.

25. The method of claim 24 , wherein the DNA is genomic DNA.

26. The method of claim 1 , wherein the amplifying in step (f) is selected from the group consisting of polymerase chain reaction, rolling circle amplification, multiple strand displacement amplification, and random prime amplification.

27. The method of claim 26 , wherein the amplifying comprises polymerase chain reaction.

28. The method of claim 26 , wherein the amplifying comprises rolling circle amplification.

29. The method of claim 1 , wherein the method further comprises a step of staining the biological specimen.

30. The method of claim 17 , wherein the second solid support is a flowcell.

Assignments (3)
CHANGE OF NAME Recorded Jul 25, 2023
From: SPATIAL TRANSCRIPTOMICS AB
To: 10X GENOMICS SWEDEN AB
Reel/Frame 064373/0360 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 28, 2021
From: FRISEN, JONAS; STAHL, PATRIK; LUNDEBERG, JOAKIM
To: SPATIAL TRANSCRIPTOMICS AB
Reel/Frame 057626/0586 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 28, 2021
From: CANN, GORDON M.; BAZARGAN, LEILA; ARAVANIS, ALEX
To: ILLUMINA, INC.
Reel/Frame 057626/0663 →
Continuity (5)
Continuation 17237670 · Apr 22, 2021
Continuation 17011923 · Sep 3, 2020
Division 15565637
Provisional Application 62145874 · Apr 10, 2015
Related Publication 20220002791A1 · Jan 6, 2022
Cited By (52)
US 12,195,790 US 12,203,134 US 12,209,280 US 12,223,751 US 12,228,544 US 12,234,505 US 12,241,060 US 12,241,890 US 12,249,085 US 12,265,079 US 12,270,077 US 12,275,988 US 12,281,357 US 12,286,673 US 12,287,264 US 12,297,486 US 12,297,487 US 12,297,488 US 12,319,955 US 12,344,892 US 12,365,935 US 12,365,942 US 12,371,688 US 12,378,607 US 12,385,083 US 12,391,979 US 12,391,980 US 12,399,123 US 12,404,544 US 12,405,264 US 12,416,603 US 12,435,363 US 12,442,045 US 12,497,654 US 12,508,590 US 12,529,094 US 12,545,949 US 12,553,805 US 12,553,898 US 12,566,113 US 12,566,114 US 12,569,847 US 12,571,029 US 12,576,400 US 12,624,475 US 12,637,706 US 12,655,473 US 12,655,478 US 12,661,647 US 12,668,835 US 12,692,492 US 12,714,996